Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Chordoma × Panobinostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Primary Myelofibrosis 1 Polycythemia Vera 1 Myelodysplastic Syndromes 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Chordoma 1 Advanced Solid Tumors 1

Interventions

Protons 2 palbociclib 1 camrelizumab 1 apatinib 1 Panobinostat 1 Mastectomy, Segmental 1 Imatinib Mesylate 1 Gelclair 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01175109 2012-12-27

Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma

University of Virginia

Phase 1 Unknown

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡